Trials / Recruiting
RecruitingNCT07035873
Pediatric Cochlear Implant Remote Programming and Assessment
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Nationwide Children's Hospital · Academic / Other
- Sex
- All
- Age
- 13 Years – 20 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, interventional study to evaluate efficacy and end user satisfaction of remote cochlear implant programming in the pediatric population. Additionally, this study will evaluate the long-term replicability of digital audio streaming (DAS) self-assessment speech perception measures via iOS mobile application.
Detailed description
The objectives of this study are to evaluate the efficacy and end user satisfaction of mobile application based (1) remote cochlear implant programming and 2) self-administered audiological test measures in older children (13 to 20 year olds). Based on existing data, we hypothesize that remote programming is efficacious, and provides positive end user satisfaction. Additionally, while our prior work has shown that application-based speech perception outcomes are replicable when measured within one session, repeated testing over time may show learning effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Remote Programming | Use of the Advanced Bionics Target CI remote programming software to complete behavioral measurements of cochlear implant function and programming via telehealth. |
| DIAGNOSTIC_TEST | Remote Speech Perception | Use of digital audio streaming (DAS) through a proprietary platform to complete remote speech perception testing of performance with cochlear implants via telehealth. |
Timeline
- Start date
- 2025-01-15
- Primary completion
- 2027-01-15
- Completion
- 2027-03-31
- First posted
- 2025-06-25
- Last updated
- 2026-04-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07035873. Inclusion in this directory is not an endorsement.